◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Pfizer Limited (PFIZER) Financial History

Name: Pfizer Limited (PFIZER) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - General · DATA UPDATED 2026-09-20

Pfizer Limited (PFIZER) operates in the Drug Manufacturers - General industry and is headquartered in Mumbai, India with about 1,244 employees. Its market capitalization is roughly ₹183 billion. In the fiscal year ended 2026-03-31, PFIZER reported ₹25.2B in revenue and ₹7.2B in net income.

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.

Interactive charts & full statements →

PFIZER Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹25.2B	₹22.8B	₹21.9B	₹24.2B
Gross Profit	₹16.3B	₹14.7B	₹14.0B	₹15.5B
Operating Income (EBIT)	₹8.5B	₹6.8B	₹5.8B	₹7.1B
Net Income	₹7.2B	₹7.7B	₹5.5B	₹6.2B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PFIZER Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹6.5B	₹6.3B	₹6.5B	₹6.4B	₹6.0B
Gross Profit	₹4.1B	₹4.1B	₹4.2B	₹4.1B	₹3.9B
Operating Income (EBIT)	₹2.3B	₹2.2B	₹2.1B	₹2.2B	₹2.0B
Net Income	₹2.0B	₹2.0B	₹1.4B	₹1.9B	₹1.9B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PFIZER Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹7.5B)	(₹1.6B)	(₹1.8B)	(₹3.0B)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PFIZER Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹49.2B	₹49.1B	₹42.3B	₹40.0B	—
Total Liabilities	₹7.2B	₹6.9B	₹6.3B	₹7.9B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PFIZER viewer.

Other Companies in Drug Manufacturers - General

4536 · Santen Pharmaceutical Co., Ltd. — JPY 549 billion
GLAXO · GlaxoSmithKline Pharmaceuticals Limited — ₹481 billion
RUBICON · Rubicon Research Limited — ₹289 billion
NOVN · Novartis AG — CHF 219 billion
MARKSANS · Marksans Pharma Limited — ₹145 billion
1093 · CSPC Pharmaceutical Group Limited — HK$102 billion
SANOFICONR · Sanofi Consumer Healthcare India Limited — ₹93 billion
SANOFI · Sanofi India Limited — ₹71 billion

← PFIX All “P” companies PFLD →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.